Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000087

Options or other derivatives

  • Chief Legal Officer acquired 3,000 shares (grant or award)
  • Chief Legal Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-18 Exercise or conversion : show line 1 in the form Performance share units −3,000 9,000 D
2026-06-18 Grant or award : show line 2 in the form Restricted stock units +3,000 3,000 D
Loading xslF345X06/wk-form4_1782249398.xml…